| 000-51598 | 77-0259335 | |
| (Commission File Number) | (IRS Employer Identification No.) | |
| 8 Crosby Drive, Bedford, Massachusetts | 01730 | |
| (Address of Principal Executive Offices) | (Zip Code) |
| o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
| o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
| o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
| o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| Item 2.02 Results of Operations and Financial Condition | ||||||||
| Item 9.01 Financial Statements and Exhibits | ||||||||
| SIGNATURES | ||||||||
| EXHIBIT INDEX | ||||||||
| Ex-99.1 Press Release issued by the registrant on July 22, 2009 | ||||||||
| 99.1 | Press Release issued by the registrant on July 22, 2009, furnished herewith. |
iRobot Corporation
July 22, 2009
By:
/s/ Glen D. Weinstein
Name:
Glen D. Weinstein
Title:
General Counsel and Secretary
Table of Contents
|
Contacts:
|
||
|
Elise Caffrey
|
Nancy Smith | |
|
Investor Relations
|
Media Relations | |
|
iRobot Corp.
|
iRobot Corp. | |
|
(781) 430-3003
|
(781) 430-3323 | |
|
ecaffrey@irobot.com
|
nsmith@irobot.com |
| | International home robot revenue in the second quarter of 2009 increased 9 percent from the second quarter of 2008 and comprised more than half of total home robot revenue in the quarter. |
| | Government & Industrial revenue was generated primarily from the sale of the iRobot PackBot 510 with FasTac Kit. During the quarter, the first PackBot 510 EODs with advanced vision and surveillance capabilities were shipped. The first ten small unmanned ground vehicles, SUGV 310s (mini-EOD), were also delivered to the Army. |
| | In the first half of 2009, operating cash flow was $11.9 million, compared with $0.2 million in the first half of 2008, as aggressive working capital management led to a $14.7 million reduction of inventory versus last year. |
|
Revenue
|
$295-$305 million | |
|
Adjusted EBITDA
|
$14-$17 million | |
|
Earnings Per Share
|
$0.00 $0.04 |
|
Revenue
|
$75-$80 million | |
|
Adjusted EBITDA
|
$3 $5 million | |
|
Earnings Per Share
|
$0.00 $0.03 |
| For the three months ended | For the six months ended | |||||||||||||||
| June 27, | June 28, | June 27, | June 28, | |||||||||||||
| 2009 | 2008 | 2009 | 2008 | |||||||||||||
|
Revenue
|
||||||||||||||||
|
Product revenue
|
$ | 52,609 | $ | 60,676 | $ | 102,300 | $ | 111,251 | ||||||||
|
Contract revenue
|
8,731 | 6,526 | 15,976 | 13,253 | ||||||||||||
|
Total
|
61,340 | 67,202 | 118,276 | 124,504 | ||||||||||||
|
Cost of Revenue
|
||||||||||||||||
|
Product revenue
|
37,098 | 44,382 | 70,537 | 80,577 | ||||||||||||
|
Contract revenue
|
7,833 | 6,352 | 15,124 | 12,099 | ||||||||||||
|
Total
|
44,931 | 50,734 | 85,661 | 92,676 | ||||||||||||
|
|
||||||||||||||||
|
Gross Margin
|
16,409 | 16,468 | 32,615 | 31,828 | ||||||||||||
|
|
||||||||||||||||
|
Operating Expense
|
||||||||||||||||
|
Research & development
|
3,896 | 4,718 | 7,474 | 8,691 | ||||||||||||
|
Selling & marketing
|
8,940 | 13,471 | 17,906 | 24,929 | ||||||||||||
|
General & administrative
|
7,365 | 7,340 | 14,495 | 14,118 | ||||||||||||
|
Total
|
20,201 | 25,529 | 39,875 | 47,738 | ||||||||||||
|
|
||||||||||||||||
|
Operating loss
|
(3,792 | ) | (9,061 | ) | (7,260 | ) | (15,910 | ) | ||||||||
|
|
||||||||||||||||
|
Other income (expense), net
|
91 | 242 | (208 | ) | 737 | |||||||||||
|
|
||||||||||||||||
|
Pre-tax loss
|
(3,701 | ) | (8,819 | ) | (7,468 | ) | (15,173 | ) | ||||||||
|
Income tax benefit
|
(1,092 | ) | (4,306 | ) | (3,072 | ) | (6,655 | ) | ||||||||
|
Net loss
|
$ | (2,609 | ) | $ | (4,513 | ) | $ | (4,396 | ) | $ | (8,518 | ) | ||||
|
|
||||||||||||||||
|
Net loss per common share:
|
||||||||||||||||
|
Basic
|
$ | (0.10 | ) | $ | (0.18 | ) | $ | (0.18 | ) | $ | (0.35 | ) | ||||
|
Diluted
|
$ | (0.10 | ) | $ | (0.18 | ) | $ | (0.18 | ) | $ | (0.35 | ) | ||||
|
|
||||||||||||||||
|
Shares used in Per Common Share Calculations:
|
||||||||||||||||
|
Basic
|
24,967 | 24,610 | 24,946 | 24,561 | ||||||||||||
|
Diluted
|
24,967 | 24,610 | 24,946 | 24,561 | ||||||||||||
|
|
||||||||||||||||
|
Stock-based compensation included in above figures:
|
||||||||||||||||
|
Cost of product revenue
|
$ | 278 | $ | 216 | $ | 491 | $ | 370 | ||||||||
|
Cost of contract revenue
|
162 | 114 | 325 | 173 | ||||||||||||
|
Research & development
|
101 | 128 | 98 | 95 | ||||||||||||
|
Selling & marketing
|
338 | 267 | 655 | 428 | ||||||||||||
|
General & administrative
|
1,016 | 808 | 1,928 | 1,405 | ||||||||||||
|
Total
|
$ | 1,895 | $ | 1,533 | $ | 3,497 | $ | 2,471 | ||||||||
| June 27, | December 27, | |||||||
| 2009 | 2008 | |||||||
| (unaudited) | (audited) | |||||||
|
Assets
|
||||||||
|
|
||||||||
|
Cash and equivalents
|
$ | 50,989 | $ | 40,852 | ||||
|
Accounts receivable, net
|
31,291 | 35,930 | ||||||
|
Unbilled revenues
|
3,459 | 2,014 | ||||||
|
Inventory, net
|
28,638 | 34,560 | ||||||
|
Deferred tax assets
|
7,565 | 7,299 | ||||||
|
Other current assets
|
5,498 | 3,340 | ||||||
|
|
||||||||
|
Total current assets
|
127,440 | 123,995 | ||||||
|
Property, plant and equipment, net
|
21,672 | 22,929 | ||||||
|
Deferred tax assets
|
4,508 | 4,508 | ||||||
|
Other assets
|
12,000 | 12,246 | ||||||
|
|
||||||||
|
Total assets
|
$ | 165,620 | $ | 163,678 | ||||
|
|
||||||||
|
|
||||||||
|
Liabilities and stockholders equity
|
||||||||
|
|
||||||||
|
Accounts payable
|
$ | 21,108 | $ | 19,544 | ||||
|
Accrued expenses
|
10,966 | 10,989 | ||||||
|
Accrued compensation
|
7,027 | 6,393 | ||||||
|
Deferred revenue and customer advances
|
2,974 | 2,632 | ||||||
|
|
||||||||
|
Total current liabilities
|
42,075 | 39,558 | ||||||
|
|
||||||||
|
Long term liabilities
|
4,229 | 4,444 | ||||||
|
|
||||||||
|
Stockholders equity
|
119,316 | 119,676 | ||||||
|
|
||||||||
|
Total liabilities and stockholders equity
|
$ | 165,620 | $ | 163,678 | ||||
|
|
||||||||
| For the three months ended | For the six months ended | |||||||||||||||
| June 27, | June 28, | June 27, | June 28, | |||||||||||||
| 2009 | 2008 | 2009 | 2008 | |||||||||||||
|
Cash flows from operating activities:
|
||||||||||||||||
|
Net loss
|
$ | (2,609 | ) | $ | (4,513 | ) | $ | (4,396 | ) | $ | (8,518 | ) | ||||
|
Adjustments
to reconcile net loss to net
cash provided by (used in) operating
activities:
|
||||||||||||||||
|
Depreciation and amortization
|
1,950 | 1,725 | 3,864 | 3,291 | ||||||||||||
|
Loss on disposal of fixed assets
|
87 | 23 | 102 | 68 | ||||||||||||
|
Stock-based compensation
|
1,895 | 1,533 | 3,497 | 2,471 | ||||||||||||
|
Benefit from deferred tax assets
|
(511 | ) | | (511 | ) | | ||||||||||
|
Non-cash director deferred compensation
|
33 | 23 | 66 | 47 | ||||||||||||
|
Changes in working capital (use) source
|
||||||||||||||||
|
Accounts receivable
|
(8,099 | ) | (2,330 | ) | 4,639 | 23,428 | ||||||||||
|
Unbilled revenue
|
(326 | ) | 419 | (1,445 | ) | 54 | ||||||||||
|
Inventory
|
2,104 | 2,928 | 5,922 | 1,934 | ||||||||||||
|
Other assets
|
(1,001 | ) | (4,047 | ) | (2,163 | ) | (8,116 | ) | ||||||||
|
Accounts payable
|
1,981 | (4,001 | ) | 1,564 | (20,732 | ) | ||||||||||
|
Accrued expenses
|
225 | 2,240 | (33 | ) | 179 | |||||||||||
|
Accrued compensation
|
1,656 | 1,501 | 634 | 2,022 | ||||||||||||
|
Deferred revenue
|
256 | (180 | ) | 342 | (628 | ) | ||||||||||
|
Change in long term liabilities
|
(108 | ) | 4,659 | (215 | ) | 4,659 | ||||||||||
|
Net cash provided by (used in) operating
activities
|
(2,467 | ) | (20 | ) | 11,867 | 159 | ||||||||||
|
|
||||||||||||||||
|
Cash flows from investing activities:
|
||||||||||||||||
|
Purchase of property and equipment
|
(1,672 | ) | (8,340 | ) | (2,448 | ) | (12,277 | ) | ||||||||
|
Purchases of investments
|
| | | (29,997 | ) | |||||||||||
|
Sales of investments
|
| | | 29,050 | ||||||||||||
|
Net cash used in investing activities
|
(1,672 | ) | (8,340 | ) | (2,448 | ) | (13,224 | ) | ||||||||
|
|
||||||||||||||||
|
Cash flows from financing activities:
|
||||||||||||||||
|
Proceeds from stock option exercises
|
132 | 162 | 459 | 732 | ||||||||||||
|
Income tax withholding payment associated
with restricted stock award vesting
|
(9 | ) | | (9 | ) | | ||||||||||
|
Tax benefit of excess stock based
compensation deductions
|
268 | 97 | 268 | 358 | ||||||||||||
|
Net cash provided by financing activities
|
391 | 259 | 718 | 1,090 | ||||||||||||
|
|
||||||||||||||||
|
Net increase (decrease) in cash and cash
equivalents
|
(3,748 | ) | (8,101 | ) | 10,137 | (11,975 | ) | |||||||||
|
Cash and cash equivalents, at beginning of
period
|
54,737 | 22,861 | 40,852 | 26,735 | ||||||||||||
|
Cash and cash equivalents, at end of period
|
$ | 50,989 | $ | 14,760 | $ | 50,989 | $ | 14,760 | ||||||||
Supplemental Information
(unaudited)
For the three months ended
For the six months ended
June 27,
June 28,
June 27,
June 28,
2009
2008
2009
2008
$
34,099
$
41,705
$
66,922
$
71,798
55
18,510
18,971
35,378
39,453
8,731
6,526
15,976
13,198
$
61,340
$
67,202
$
118,276
$
124,504
$
6,037
$
7,884
$
11,689
$
15,745
$
4,542
$
2,172
$
8,931
$
5,374
$
19,741
$
18,175
$
37,279
$
28,581
$
1,640
$
398
$
4,455
$
1,209
$
159
$
157
$
160
$
160
$
93
$
99
$
88
$
104
$
10,109
$
10,759
$
20,261
$
18,828
6,300
5,709
12,354
13,000
$
16,409
$
16,468
$
32,615
$
31,828
192
237
375
406
151
170
301
326
$
17,537
$
22,355
$
17,537
$
22,355
52
36
52
36
5.2
4.1
5.2
4.1
$
(2,467
)
$
(20
)
$
11,867
$
159
508
482
508
482
| For the three months ended | For the six months ended | |||||||||||||||
| June 27, | June 28, | June 27, | June 28, | |||||||||||||
| 2009 | 2008 | 2009 | 2008 | |||||||||||||
|
Net loss
|
$ | (2,609 | ) | $ | (4,513 | ) | $ | (4,396 | ) | $ | (8,518 | ) | ||||
|
Interest income, net
|
(15 | ) | (260 | ) | (36 | ) | (829 | ) | ||||||||
|
Income tax benefit
|
(1,092 | ) | (4,306 | ) | (3,072 | ) | (6,655 | ) | ||||||||
|
Depreciation
|
1,820 | 1,725 | 3,613 | 3,291 | ||||||||||||
|
Amortization
|
128 | | 251 | | ||||||||||||
|
|
||||||||||||||||
|
EBITDA
|
(1,768 | ) | (7,354 | ) | (3,640 | ) | (12,711 | ) | ||||||||
|
|
||||||||||||||||
|
Stock-based compensation expense
|
1,895 | 1,533 | 3,497 | 2,471 | ||||||||||||
|
|
||||||||||||||||
|
Adjusted EBITDA
|
$ | 127 | $ | (5,821 | ) | $ | (143 | ) | $ | (10,240 | ) | |||||